Samsung Pharm (001360) — Capital Reinvestment Ratio
Samsung Pharm (001360) has a Capital Reinvestment Ratio of 0.40x as of June 2022, meaning it reinvests 0% of its operating cash flow (₩1.59 Billion) in capital expenditures (₩638.30 Million). Check Samsung Pharm tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Samsung Pharm Capital Reinvestment Ratio (2017–2017)
This chart tracks Samsung Pharm's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see 001360 cash flow conversion.
Annual Capital Reinvestment Ratio for Samsung Pharm (2017–2017)
Year-by-year Capital Reinvestment Ratio for Samsung Pharm from 2017 to 2017. See 001360 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 1.19x | ₩5.15 Billion | ₩6.11 Billion | — |